DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01)

ABSTRACT: The main objective of this study is to test the safety and effectiveness of DS-8201a for participants with HER2-expressing advanced colorectal cancer.

DISEASE(S): Colorectal Neoplasm,Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2262173 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR